The effect of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cells

British Journal of Haematology
T A SylwestrowiczA V Hoffbrand

Abstract

Intracellular deoxynucleoside triphosphate pools of normal bone marrow, thymocytes and cells from patients with ALL and AML were measured after 2 h incubation with deoxycoformycin (dCF) 10(-5) M and deoxyadenosine (AdR) 10(-4) M in vitro and after another 30 min incubation in the absence of dCF and AdR ('chase' experiment). Incubation with dCF and AdR resulted in a significant rise of dATP concentrations in all groups (the highest rises occurring in the leukaemic groups particularly in AML and Thy-ALL). The concentrations of the other three deoxyribonucleoside triphosphates fell in all groups. The dATP level fell during the 'chase' period but in Thy-ALL and thymocytes this fall was insignificant and slower than in the other groups. This suggests that not only intracellular build-up of dATP but also the capacity of the cell to degrade dATP is important for in vivo cytotoxicity of dCF treatment. These results help to explain the differences in response to dCF of the different leukaemias.

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·D A CarsonJ E Seegmiller
May 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·R L WortmannI H Fox
Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·A CohenD W Martin
Jun 14, 1979·The New England Journal of Medicine·G H ReamanD G Poplack
May 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·D A CarsonL Thompson
Apr 1, 1975·European Journal of Clinical Investigation·M H TattersallA V Hoffbrand
Mar 1, 1970·Analytical Biochemistry·U Lindberg, L Skoog
Jan 1, 1968·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·A Agnoli
Jan 1, 1968·Scandinavian Journal of Clinical and Laboratory Investigation·A Gottfries
Feb 15, 1981·The Biochemical Journal·M R TaheriA V Hoffbrand
Oct 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·M F SiawJ J Hutton
Jan 1, 1981·Leukemia Research·M F GreavesG Goldstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.